How to buy the drug Aceminid?

Asciminib, also known asAsciminib, is a new type of tyrosine kinase inhibitor (TKI) that has shown significant results in the treatment of chronic myelogenous leukemia (CML). This drug is specially designed for patients who are resistant to traditional TKIs (such as imatinib, dasatinib, etc.). Especially when fighting against BCR-ABL T315I mutated CML, aximini has shown excellent efficacy.

Aximini has a unique therapeutic mechanism. It works by targeting the myristoyl binding pocket of the BCR-ABL fusion protein, which gives it significant therapeutic advantages. Aceminib is more effective at inhibiting multiple mutated forms of BCR-ABL than earlier TKIs, especially in patients who have developed drug resistance. Clinical studies have confirmed that patients taking aceminib achieve higher rates of cytological and molecular responses, thereby improving their survival and quality of life.

However, Acemini has not yet been officially launched in the Chinese market, which means that patients cannot purchase the drug directly through domestic pharmacies or hospitals. In most cases, patients need to obtain Asiminib through overseas channels.

Regarding the price of Acemini, it will vary depending on the region and sales channel. Generally speaking, the price of original drugs may be around tens of thousands of yuan, while the price of some generic drugs may be more affordable, around 4,000 yuan. Therefore, patients should carefully compare prices when purchasing to find the most economical option for them.

Overall, aceminib offers new therapeutic hope for patients with chronic myelogenous leukemia, especially those who have developed resistance to traditional treatments. Although this drug cannot be purchased directly in China, it is still feasible to obtain it through legal overseas channels. During the purchase process, patients should follow legal procedures and maintain close communication with medical professionals to ensure the safety and effectiveness of medication.